Fractional Executive

For health systems and organizations that need senior executive expertise — without a full-time hire. Dr. Golden embeds as a fractional Chief Medical Officer, Chief Quality Officer, or Chief Health Equity Officer, bringing the clinical authority and operational experience to translate quality frameworks and performance metrics into reliable, equitable care delivery that holds under scrutiny.

Begin conversation
Care-hands-black-arrow

Dr. Golden is a dynamic leader who is able to enlist diverse stakeholders to execute culture transformation.

Mark E. Anderson MD, PhD, Executive Vice President for Medical Affairs,Dean for Division of the Biological Sciences and Pritzker School of Medicine

Fractional Executive Leadership means Dr. Golden steps into your organization as a senior leader

With real authority, real accountability, and real results. This is not consulting from the outside. It's embedded, hands-on executive partnership that fills a critical gap without the timeline or cost of a full-time search. Together we focus on:

  • Building and operationalizing quality and safety frameworks that perform under regulatory scrutiny
  • Translating accreditation requirements into workflows your teams can sustain
  • Developing and leading health equity strategy with measurable outcomes
  • Strengthening clinical governance, performance dashboards, and accountability structures

Begin conversation
Care-hands-black-arrow
The transformation

What changes as a result?

An organization that doesn't just pass accreditation — but is built to maintain it
Quality and equity metrics that move in the right direction and stay there
Leadership confidence and organizational capacity that outlasts the engagement
A culture where safety, equity, and performance are embedded — not added on

Who this is for

This service is designed for health systems and community hospitals that need experienced executive leadership now — whether they're navigating a leadership vacancy, preparing for a high-stakes accreditation cycle, or building the internal infrastructure for quality and equity that doesn't yet exist. It's the right fit when your organization is:

Care-hands-donation-details-icon
Operating without a CMO, CQO, or Chief Health Equity Officer — or needs to augment existing capacity
Care-hands-donation-details-icon
Facing regulatory pressure, a Joint Commission survey, or performance gaps that require urgent senior attention
Care-hands-donation-details-icon
Scaling quality or equity programs that need executive ownership to succeed
Care-hands-donation-details-icon
In the middle of a leadership transition and can't afford to lose momentum
Begin conversation
Care-hands-black-arrow

Who benefits the most

Begin conversation
Care-hands-black-arrow
Those who need a trusted executive

CEOs (Chief Executive Officers) and COOs (Chief Operating Officers) who need a trusted clinical executive in the room

Those who need a thought partner

Chief Nursing Officers and Chief Medical Officers who need a peer and thought partner

Teams searching for strategic direction

Quality, safety, and equity teams who need senior sponsorship and strategic direction

Boards seeking assurance

Boards seeking assurance that clinical performance and compliance are under capable leadership

The G.O.L.D.E.N. Lens Framework

Healthcare transformation fails when strategy, people, and execution aren’t aligned

The G.O.L.D.E.N. Lens™ is the foundation of every engagement at Golden Touch & Associates — from fractional executive leadership to keynote speaking, strategic advising to leadership coaching.
Begin conversation
Care-hands-black-arrow

G  —  Grounded in Evidence

Evidence-based, outcomes-focused, accreditation-aligned

Every strategy begins with data, quality metrics, and best practices — and with the discipline to understand their limits in the complexity of real-world care.

“We respect the data — and we interrogate it.”

O  —  Oriented to People

Human-centered, patient- and community-informed

Sustainable change happens at the point of care and connection — which means centering the lived experience of patients, clinicians, employees, and communities in every improvement effort.

“No metric matters if people don’t.”

L  —  Led by Purpose

Mission-driven, equity-informed

Improvement work must be anchored in organizational mission, values, and equity commitments — not shaped by compliance requirements or the optics of the moment.

“Purpose is a strategy, not a slogan.”

D  —  Designed for Execution

Strategy-driven, operationally realistic

Vision without execution is aspiration. Every strategy is translated into practical, implementable plans that leaders and frontline teams can actually carry forward — and sustain.

“Big thinking, real-world delivery.”

E  —  Engaging Stakeholders

Clinicians, employees, and community as partners

Trust and alignment across silos don’t happen by announcement — they are built deliberately, turning disengaged stakeholders into co-owners of the change they are being asked to lead.

“Nothing sustainable is built alone.”

N  —  Nurturing Resilience

Adaptive, future-ready, inspirational leadership

The goal is not to help organizations survive disruption — it is to help them grow stronger through it, building cultures that can learn, adapt, and lead with confidence through uncertainty.

“Resilience is built before the crisis.”

Reviews

Hear what people say

Dr. Golden has been a renowned leader in the field of hospital inpatient management for patients with diabetes mellitus. Many years ago, when I was first envisioning the enhancement of our diabetes inpatient consultation services, I met with Dr. Golden to learn of her experiences at Hopkins and how we might benefit from a similar approach. In 2019, Dr. Golden came and presented to our group and inspired us with the vision of optimizing glycemic management in our complex patient population with diabetes and cancer. With inspiration from the work done by her and her team at JHMI, we developed an institutional glycemic management program to meet best practice standards as established by The Joint Commission, and achieved disease state certification for inpatient diabetes in August 2025. The early advice and assistance from Dr. Golden and her colleagues eventually led to our institution being recognized as one of an elite group of fewer than 1% of hospitals nationwide with this achievement, and the only free standing cancer center with this recognition.
Steven Sherman,
MD, Chair,
Department of Endocrine Neoplasia and Hormonal Disorders at MD Anderson Cancer Center
Sherita was one of the keynotes on a panel at a past annual conference and we enjoyed her portion so much that we are inviting her back to take center stage this time. I loved working with her! She was an inspiration to our audience of diabetes care and education specialists.
Jodi Lavin-Tompkins Former Director of Accreditation/Content Development Association of Diabetes Care & Education Specialists
I had the distinct honor and privilege of moderating a fireside chat with Dr. Sherita Golden at the Pediatric Health Equity Network of Excellence (PHENX) scholars convening last weekend. Not only were Dr. Golden's keynote remarks invaluable for the early career scholars, but the senior Ecosystem Change for Health Equity Research (ECHER) leadership cohort also benefited from Sherita's deep experience and insights. To quote one of the participants regarding Dr. Golden's contributions to the PHENX/ECHER convening, "This weekend was the most impact-per-minute I have ever experienced at a conference or career development activity."
Joseph Wright, MD, MPH, Senior Vice President and Chief Health Equity Officer American Academy of Pediatrics
It was a privilege to welcome Dr. Sherita Hill Golden to the American Diabetes Association Clinical Update Conference, where she delivered a powerful session on “Closing Gaps in Diabetes Management.” What resonated most deeply with me was her ability to connect evidence, equity, and lived experience into a clear and actionable vision. She reminded us that closing gaps is not an abstract goal, it is a responsibility that requires intentional design of care models that truly meet people where they are. As Chair of this conference, I am continually listening for voices that move us forward, not just in knowledge, but in alignment. Dr. Golden is one of those voices. She is not only advancing the science of diabetes care, but also shaping the conditions for more equitable, person-centered systems to emerge.
Barbara Eichorst, MS, MD, CDCES, Vice President, Health Care Programs American Diabetes Association
Dr. Sherita Golden's fireside chat with Dr. Joseph Wright at the AAP meeting was a unique blend of storytelling and vision. The room was spellbound by her personal narrative, her vision for the future, and her ability to link her work to the issues facing medicine and society. I would highly recommend Dr. Golden as a keynote focused on equity, quality, leadership development, and more!
Helen Burstin, MD, MPH, CEO Council of Medical Specialty Societies
As a graduate student and someone living with Type 1 diabetes, working alongside Dr. Golden helped me better understand diabetes care and technology from a clinician’s perspective while still centering the real, lived experiences of people with diabetes. What stands out most about her is her genuine curiosity and care for understanding patients beyond clinical numbers, especially the emotional and psychosocial realities that are often difficult to share. Dr. Golden leads with empathy, intention, and openness. She is deeply knowledgeable and embodies mentorship in her approach to care. I saw this clearly during The Diabaddie Organization’s Diabaddie Tech Link Up Panel, where she spoke to over 100 community members about access to and the benefits of advanced diabetes technology. She is not only a physician, but a true advocate who shows up in the community and meets people where they are.
Antoinette Watkins, Founder & Executive Director, The Diabaddie Organization (501c3) Diabetes Advocate and MPH graduate student
I’ve had the privilege of being mentored by Dr. Sherita Golden, whose visionary leadership and genuine support have shaped my career. Over the past decade, she inspired and gently coached me to grow one of the largest #EndocrineHospitalist programs in the country and guided me in establishing the Inpatient Diabetes Management Services across our community hospitals at Johns Hopkins Medicine. Her mentorship blends insight, compassion, and strategic vision. She is an exceptional leader and role model.
Mihail (“Misha”) Zilbermint, MD, MBA Associate Professor Division of Endocrinology, Diabetes, and Metabolism Johns Hopkins University School of Medicine and Director, Endocrine Hospitals Johns Hopkins Community Physicians
Since my recruitment to Johns Hopkins as the division chief of pediatric endocrinology, Sherita has been an invaluable career and life mentor. She helped to guide and advise me as I learned the Hopkins system, and was a staunch supporter through my promotion process to full professor. Sherita goes beyond just meeting with a mentee, and truly listens to the person and his/her situation. She is incredibly down to earth, and just a caring, empathetic individual. We have bonded on the challenges of balancing busy careers, family, as well as navigating health care for aging parents. I always know that I can count on her, which is invaluable.
Sheela Magge MD, MSCI, Professor and Director Division of Pediatric Endocrinology, Department of Pediatrics Johns Hopkins University School of Medicine
I have known Sherita for over 20 years and have had the good fortune to have her as my primary academic mentor; beyond her scientific accomplishments, she is an exceptionally gifted writer, engaging communicator, accomplished program builder and leader, and a fierce advocate for equity in healthcare. Working with Sherita as my mentor has been transformative. She has supported me through key career transitions, guided grant and manuscript development, encouraged leadership roles, and championed my work. Her balance of high standards with genuine care fosters confidence, resilience, and excellence. I highly recommend Sherita as a mentor, collaborator, and leader; her commitment to mentorship not only elevates individuals but strengthens the broader academic and healthcare communities. •
Nestoras Mathioudakis MD, MHS, Associate Professor of Medicine Division of Endocrinology, Diabetes, and Metabolism Johns Hopkins University School of Medicine
Dr. Golden is the kind of mentor who changes the trajectory of lives. Her ability to nurture scientific excellence while also caring deeply about the whole person is what sets her apart. During our weekly meetings, Dr. Golden guided me not only through research and career decisions, but also through essential conversations about leadership, purpose, and work-life balance—modeling empathy, humility, and integrity at every step. This blend of scientific brilliance and human connection is exactly why she is widely recognized as an awe-inspiring mentor who has shaped the careers of hundreds across medicine, public health, and science. I recommend her without reservation to anyone seeking a transformative mentor, collaborator, or leader!
Joshua J. Joseph MD, MPH, FAHA, Associate Professor of Medicine, Division of Endocrinology, Diabetes, and Metabolism Ohio State University College of Medicine Deputy Director of The Ohio Statue University Clinical and Translational Science Institute (CTSI)
She is a dynamic leader and charismatic speaker who is able to enlist diverse stakeholders to engage employees and execute culture transformation
Mark E. Anderson MD, PhD, Executive Vice President for Medical Affairs Dean for Division of the Biological Sciences and Pritzker School of Medicine
Dr. Golden has been a renowned leader in the field of hospital inpatient management for patients with diabetes mellitus. Many years ago, when I was first envisioning the enhancement of our diabetes inpatient consultation services, I met with Dr. Golden to learn of her experiences at Hopkins and how we might benefit from a similar approach. In 2019, Dr. Golden came and presented to our group and inspired us with the vision of optimizing glycemic management in our complex patient population with diabetes and cancer. With inspiration from the work done by her and her team at JHMI, we developed an institutional glycemic management program to meet best practice standards as established by The Joint Commission, and achieved disease state certification for inpatient diabetes in August 2025. The early advice and assistance from Dr. Golden and her colleagues eventually led to our institution being recognized as one of an elite group of fewer than 1% of hospitals nationwide with this achievement, and the only free standing cancer center with this recognition.
Steven Sherman MD, Chair Department of Endocrine Neoplasia and Hormonal Disorders at MD Anderson Cancer Center
Dr. Golden exemplifies the expertise, integrity, and visionary leadership required to guide companies at the highest level. Her distinguished career in clinical medicine, research, and executive leadership demonstrates exceptional readiness to provide strategic counsel and mentorship. Respected for her mentorship and inclusive leadership, Dr. Golden has guided countless physicians and scientists to success in academic and administrative roles. Her clarity, empathy, and vision foster both institutional and individual growth. A frequent keynote speaker, she is widely recognized for translating complex medical and policy issues into actionable strategies and for her advocacy in health equity, workforce diversity, and patient-centered care. Dr. Golden offers a rare combination of clinical insight, strategic acumen, and organizational experience.
David Wilkes MD, Dean Emeritus University of Virginia School of Medicine and CEO Amos Institute for Medical Faculty Development
While serving as Vice President of Medical Affairs and Chair of the Patient Safety Committee for the hospital, I had the pleasure of collaborating closely with Dr. Golden in her role overseeing The Johns Hopkins Hospital’s Glucose Management Program. Under her leadership, the group developed numerous order sets, policies, and other clinical decision support tools to systematically improve management of diabetes and hyperglycemia among patients throughout the hospital. Her efforts generated significant results, including a marked decline in average mean blood glucose for patients (safely below recommended glucose targets) and a significant reduction in hypoglycemic event rates. These are remarkable accomplishments thanks to the work of a remarkable leader. It is an honor and a privilege to recommend Dr. Golden as an innovative clinical program builder and leader.
Redonda Miller MD, MBA, President Johns Hopkins Hospital

Frequently asked support questions

What makes your approach different?

We don’t separate strategy from humanity. The G.O.L.D.E.N. Lens™ Framework weaves evidence, people, purpose, execution, stakeholder engagement, and resilience into every engagement — because sustainable transformation requires all of them working together. Dr. Golden has lived this work inside large, complex health systems at the most senior levels of leadership. She knows what moves organizations forward, and what doesn’t.

What is the investment?

We work with organizations of all sizes — from large academic health systems to regional networks to community organizations — because the challenges around quality, safety, leadership, and resilience are not exclusive to any one type of institution. Every engagement is scoped to your context, your goals, and your capacity. The best way to understand what a partnership might look like is to start a conversation. There is no obligation in reaching out.

What does working with Golden Touch & Associates look like — and how long does it take?

Every engagement begins with listening — to your challenges, your goals, and your organization’s story. From there, the shape of the work depends on what you need: regular strategic advisory sessions, embedded fractional executive leadership, a keynote or workshop that shifts how your team thinks and leads, or individualized coaching that helps a leader clarify their path forward. Most consulting and advisory engagements span six to twenty-four months; keynotes and workshops deliver impact in a single session and build capacity that leaders carry forward. Whatever the form, we measure progress in shifts of culture, capability, and outcomes — not just quarterly metrics.